Efficacy of Lactoferin in HPV Clearance
- Conditions
- virus clearance in HPV+ patients.Cervical high risk human papillomavirus (HPV) DNA test positiveR87.810
- Registration Number
- IRCT20231004059608N1
- Lead Sponsor
- Pasture Institute of Iran
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 80
Age: 25 to 50 years
Gender: Female
Marital Status: Married/Single
HPV positive patients (genotypes 16, 18, 31, 33, 39, 45, and 52)
Normal pap smear
Low grade pathology / CIN1
Pregnant women
observation of internal/external warts
history of surgery
?alchohol consumption
AIDS (HIV+)
Drug use within 90 days
People with systemic immunosuppressive disorders
Patients who have received local or systemic treatment in the last three months.
Abnormal pap smear
High grade pathology
Cancer
Conization history
Suffering from chronic diseases (diabetes, fatty liver and metabolic diseases, etc.)
Having more than 3 sexual partners
Patients with a history of treatment with Eldara and similar drugs (local and systemic)
History of Allergy, sensitivity to medicine, Anaphylaxis shock
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HPV clearance in HPV+ after 6 months. Timepoint: 0-3-6 month. Method of measurement: hpv genotyping test.;Pap smear. Timepoint: 0-3-6 month. Method of measurement: cytology and pap smear.
- Secondary Outcome Measures
Name Time Method